Brian G. Atwood
Mr. Atwood has served as a member of our board of directors since our inception. In 1999, he co-founded and currently serves as a Managing Director for Versant Ventures, a healthcare-focused venture capital firm. Prior to founding Versant Ventures, Mr. Atwood served as a general partner of Brentwood Associates, a venture capital firm. Mr. Atwood also serves on the boards of directors of several pharmaceutical and biotechnology companies, including Cadence Pharmaceuticals, Five Prime Therapeutics, Helicos BioSciences, Immune Design, OpGen, PhaseRx, Trius Therapeutics, and Veracyte. Mr. Atwood also served on the board of Pharmion Corporation from January 2000 until the company’s acquisition in 2008. Mr. Atwood holds a B.S. in biological sciences from the University of California, Irvine, a M.S. in ecology from the University of California, Davis, and an M.B.A. from Harvard University.
Additional Information
No additional information has been added yet. Add a LinkedIn URL.
Invested In
No investments.